Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed through a tissue sample (biopsy) with head and neck cancer that has come back or spread to other parts of the body, cannot be treated with surgery or radiation therapy to remove or cure it, and are being considered for their first round of drug-based treatment (such as chemotherapy or other systemic medicines)
- People whose cancer cells test positive for a protein called PD-L1, with a score of 1 or higher using a measurement called the Combined Positive Score (CPS) (confirm with trial site)
Who may not be able to join:
- People who have any medical reason that would make it unsafe for them to receive a type of cancer treatment called immune checkpoint inhibitors — these are drugs that help the immune system recognise and fight cancer (confirm with trial site for specific reasons that may apply)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390620908190
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Predictive value of 18F-FDG PET/CT metabolic changes at 6 weeks for response to pembrolizumab
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.